360 High-Risk Vulnerability Immunization Tool V2.0 vs Xcitium ZeroDwell: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Xcitium ZeroDwell: Real-time virtualization tech that contains unknown executables in containers. built by Xcitium. Core capabilities include Real-time virtualization of unknown executables, Automatic detection of unknown files, Containerized execution environment for unknowns..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Xcitium ZeroDwell differentiates with Real-time virtualization of unknown executables, Automatic detection of unknown files, Containerized execution environment for unknowns.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Xcitium ZeroDwell is developed by Xcitium. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Xcitium ZeroDwell serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.